|
|
|
Insider
Information: |
Friedman Paul A |
Relationship: |
Director |
City: |
Palo Lato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
964,465 |
|
Indirect Shares
|
670,540 |
|
|
Direct
Value |
$60,444,928 |
|
|
Indirect Value
|
$161,059,749 |
|
|
Total
Shares |
1,635,005 |
|
|
Total
Value |
$221,504,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
14.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director |
2020-05-26 |
256,813 |
2020-05-26 |
15,000 |
Premium* |
|
Bausch & Lomb, Inc. |
BOL.04 |
Director |
2007-10-26 |
0 |
2004-06-01 |
0 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2014-12-24 |
3,000 |
2014-12-24 |
0 |
Premium* |
|
Madrigal Pharmaceuticals Inc |
MDGL |
|
2024-04-08 |
185,735 |
2024-04-08 |
655,540 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-04-03 |
18,819 |
2016-10-03 |
0 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2021-07-21 |
0 |
2017-11-29 |
0 |
Premium* |
|
Prelude Therapeutics Inc |
PRLD |
Director |
2020-09-29 |
500,098 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
97 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INCY |
Incyte Corp |
Chief Executive Officer |
|
2013-05-06 |
4 |
OE |
$9.41 |
$253,088 |
D/D |
23,700 |
391,868 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Executive Officer |
|
2013-12-20 |
4 |
D |
$50.11 |
$1,220,179 |
D/D |
(24,350) |
417,518 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Executive Officer |
|
2010-07-07 |
4 |
OE |
$5.46 |
$155,034 |
D/D |
25,142 |
289,707 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Executive Officer |
|
2012-07-10 |
4 |
OE |
$3.11 |
$189,442 |
D/D |
25,186 |
334,893 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
|
|
2024-04-08 |
4 |
AS |
$242.95 |
$6,467,491 |
D/D |
(26,270) |
185,735 |
0 |
% |
|
MDGL |
Madrigal Pharmaceuticals ... |
|
|
2024-04-08 |
4 |
OE |
$9.45 |
$248,252 |
D/D |
26,270 |
212,005 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Chief Executive Officer |
|
2023-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
26,668 |
26,668 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Director |
|
2024-04-03 |
4 |
AS |
$242.00 |
$6,718,002 |
D/D |
(27,407) |
185,735 |
0 |
% |
|
MDGL |
Madrigal Pharmaceuticals ... |
Director |
|
2024-04-03 |
4 |
OE |
$9.45 |
$258,996 |
D/D |
27,407 |
213,142 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Director |
|
2024-04-05 |
4 |
AS |
$240.10 |
$6,721,081 |
D/D |
(27,613) |
185,735 |
0 |
% |
|
MDGL |
Madrigal Pharmaceuticals ... |
Director |
|
2024-04-05 |
4 |
OE |
$9.45 |
$260,943 |
D/D |
27,613 |
213,348 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-11-16 |
4 |
S |
$105.24 |
$3,000,077 |
D/D |
(28,507) |
269,011 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2014-02-20 |
4 |
S |
$63.51 |
$2,118,313 |
D/D |
(33,354) |
417,518 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2014-02-20 |
4 |
OE |
$3.11 |
$103,731 |
D/D |
33,354 |
450,872 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2014-02-19 |
4 |
S |
$62.66 |
$2,563,985 |
D/D |
(40,919) |
417,518 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2014-02-19 |
4 |
OE |
$3.11 |
$127,258 |
D/D |
40,919 |
458,437 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-03-17 |
4 |
OE |
$18.32 |
$763,816 |
D/D |
41,693 |
339,211 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-03-17 |
4 |
S |
$148.18 |
$6,178,069 |
D/D |
(41,693) |
297,518 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Executive Officer |
|
2005-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
116,700 |
|
- |
|
INCY |
Incyte Corp |
officerTitle |
|
2005-11-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,000 |
169,400 |
|
- |
|
INCY |
Incyte Corp |
Director |
|
2017-02-23 |
4 |
S |
$120.32 |
$6,016,000 |
D/D |
(50,000) |
297,518 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-02-23 |
4 |
OE |
$18.32 |
$916,000 |
D/D |
50,000 |
347,518 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2015-05-27 |
4 |
OE |
$14.72 |
$1,017,623 |
D/D |
69,132 |
366,650 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2015-05-27 |
4 |
S |
$107.19 |
$7,435,026 |
D/D |
(69,132) |
297,518 |
0 |
- |
|
MDGL |
Madrigal Pharmaceuticals ... |
Chief Executive Officer |
|
2018-06-11 |
4 |
S |
$287.46 |
$21,135,784 |
I/I |
(73,526) |
655,540 |
0 |
- |
|
97 Records found
|
|
Page 3 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|